Madrigal Pharmaceuticals, Inc. (MDGL)
USD 315.48
(-3.73%)
USD 315.48
(-3.73%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -373.63 Million USD | -24.83% |
| 2022 | -299.31 Million USD | -24.16% |
| 2021 | -241.07 Million USD | -22.1% |
| 2020 | -197.44 Million USD | -171.17% |
| 2019 | -72.81 Million USD | -121.91% |
| 2018 | -32.81 Million USD | -5.32% |
| 2017 | -31.15 Million USD | -18.06% |
| 2016 | -26.38 Million USD | 61.57% |
| 2015 | -68.67 Million USD | 20.3% |
| 2014 | -86.16 Million USD | 4.47% |
| 2013 | -90.19 Million USD | -43.64% |
| 2012 | -62.79 Million USD | -32.52% |
| 2011 | -47.38 Million USD | -26.46% |
| 2010 | -37.46 Million USD | -147.37% |
| 2009 | 79.08 Million USD | 185.39% |
| 2008 | -92.61 Million USD | -45.87% |
| 2007 | -63.49 Million USD | -10.87% |
| 2006 | -57.27 Million USD | 16.83% |
| 2005 | -68.86 Million USD | -49.92% |
| 2004 | -45.93 Million USD | -64.77% |
| 2003 | -27.87 Million USD | 22.89% |
| 2002 | -36.15 Million USD | -9389.24% |
| 2001 | -381 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -151.97 Million USD | -3.0% |
| 2024 Q1 | -147.54 Million USD | -31.51% |
| 2024 Q3 | -106.96 Million USD | 29.62% |
| 2023 Q2 | -85.8 Million USD | -10.29% |
| 2023 Q1 | -77.79 Million USD | 11.18% |
| 2023 FY | -373.63 Million USD | -24.83% |
| 2023 Q3 | -98.74 Million USD | -15.08% |
| 2023 Q4 | -112.19 Million USD | -13.63% |
| 2022 FY | -299.31 Million USD | -24.16% |
| 2022 Q2 | -71.51 Million USD | -24.18% |
| 2022 Q1 | -57.58 Million USD | 10.79% |
| 2022 Q4 | -87.58 Million USD | -5.91% |
| 2022 Q3 | -82.69 Million USD | -15.65% |
| 2021 Q2 | -61.65 Million USD | -17.33% |
| 2021 Q1 | -52.54 Million USD | 11.12% |
| 2021 Q3 | -63.1 Million USD | -2.35% |
| 2021 Q4 | -64.54 Million USD | -2.3% |
| 2021 FY | -241.07 Million USD | -22.1% |
| 2020 FY | -197.44 Million USD | -171.17% |
| 2020 Q4 | -59.12 Million USD | -2.0% |
| 2020 Q3 | -57.96 Million USD | -18.24% |
| 2020 Q1 | -36.13 Million USD | -30.26% |
| 2020 Q2 | -49.02 Million USD | -35.67% |
| 2019 Q3 | -21.42 Million USD | -8.78% |
| 2019 FY | -72.81 Million USD | -121.91% |
| 2019 Q4 | -27.74 Million USD | -29.45% |
| 2019 Q2 | -19.69 Million USD | -30.63% |
| 2019 Q1 | -15.08 Million USD | -31.42% |
| 2018 FY | -32.81 Million USD | -5.32% |
| 2018 Q1 | -6.36 Million USD | 24.64% |
| 2018 Q2 | -6.46 Million USD | -1.51% |
| 2018 Q3 | -8.51 Million USD | -31.76% |
| 2018 Q4 | -11.47 Million USD | -34.81% |
| 2017 FY | -31.15 Million USD | -18.06% |
| 2017 Q3 | -8.36 Million USD | -0.19% |
| 2017 Q2 | -8.34 Million USD | -39.14% |
| 2017 Q1 | -5.99 Million USD | 22.58% |
| 2017 Q4 | -8.44 Million USD | -0.98% |
| 2016 FY | -26.38 Million USD | 61.57% |
| 2016 Q2 | -3.37 Million USD | 48.21% |
| 2016 Q3 | -14.04 Million USD | -315.77% |
| 2016 Q4 | -7.74 Million USD | 44.84% |
| 2016 Q1 | -6.52 Million USD | 38.08% |
| 2015 FY | -68.67 Million USD | 20.3% |
| 2015 Q4 | -10.53 Million USD | 40.23% |
| 2015 Q3 | -17.62 Million USD | 10.97% |
| 2015 Q2 | -19.8 Million USD | 4.38% |
| 2015 Q1 | -20.7 Million USD | -1.74% |
| 2014 Q3 | -19.96 Million USD | 10.41% |
| 2014 Q2 | -22.28 Million USD | 5.4% |
| 2014 FY | -86.16 Million USD | 4.47% |
| 2014 Q1 | -23.55 Million USD | 2.5% |
| 2014 Q4 | -20.35 Million USD | -1.93% |
| 2013 FY | -90.19 Million USD | -43.64% |
| 2013 Q3 | -22.51 Million USD | 1.19% |
| 2013 Q4 | -24.16 Million USD | -7.32% |
| 2013 Q2 | -22.78 Million USD | -9.93% |
| 2013 Q1 | -20.72 Million USD | -14.37% |
| 2012 Q4 | -18.12 Million USD | -20.85% |
| 2012 Q2 | -14.62 Million USD | 2.86% |
| 2012 Q1 | -15.05 Million USD | -40.1% |
| 2012 Q3 | -14.99 Million USD | -2.57% |
| 2012 FY | -62.79 Million USD | -32.52% |
| 2011 Q2 | -12.5 Million USD | -9.66% |
| 2011 Q1 | -11.4 Million USD | -29.22% |
| 2011 Q3 | -12.73 Million USD | -1.86% |
| 2011 Q4 | -10.74 Million USD | 15.64% |
| 2011 FY | -47.38 Million USD | -26.46% |
| 2010 Q2 | -9.07 Million USD | 2.51% |
| 2010 FY | -37.46 Million USD | -147.37% |
| 2010 Q4 | -8.82 Million USD | 14.02% |
| 2010 Q3 | -10.26 Million USD | -13.09% |
| 2010 Q1 | -9.3 Million USD | -32.27% |
| 2009 Q1 | -23.49 Million USD | 9.46% |
| 2009 Q2 | -8.49 Million USD | 63.85% |
| 2009 Q3 | 118.11 Million USD | 1490.45% |
| 2009 Q4 | -7.03 Million USD | -105.96% |
| 2009 FY | 79.08 Million USD | 185.39% |
| 2008 Q1 | -17.65 Million USD | -13.69% |
| 2008 FY | -92.61 Million USD | -45.87% |
| 2008 Q4 | -25.95 Million USD | 1.4% |
| 2008 Q3 | -26.32 Million USD | -15.98% |
| 2008 Q2 | -22.69 Million USD | -28.58% |
| 2007 Q2 | -16.74 Million USD | -2.36% |
| 2007 Q1 | -16.35 Million USD | -30.98% |
| 2007 FY | -63.49 Million USD | -10.87% |
| 2007 Q3 | -14.87 Million USD | 11.15% |
| 2007 Q4 | -15.52 Million USD | -4.36% |
| 2006 Q2 | -14.92 Million USD | 0.0% |
| 2006 Q4 | -12.48 Million USD | 16.35% |
| 2006 Q1 | -14.92 Million USD | 3.64% |
| 2006 FY | -57.27 Million USD | 16.83% |
| 2006 Q3 | -14.92 Million USD | 0.0% |
| 2005 Q3 | -26.68 Million USD | 0.0% |
| 2005 Q4 | -15.49 Million USD | 41.95% |
| 2005 Q2 | -26.68 Million USD | -49.44% |
| 2005 FY | -68.86 Million USD | -49.92% |
| 2005 Q1 | -17.85 Million USD | 0.0% |
| 2004 FY | -45.93 Million USD | -64.77% |
| 2004 Q1 | -8.75 Million USD | 0.0% |
| 2003 FY | -27.87 Million USD | 22.89% |
| 2002 FY | -36.15 Million USD | -9389.24% |
| 2001 FY | -381 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -44.913% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -230.76% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -39817.735% |
| Autolus Therapeutics plc | -208.38 Million USD | -79.3% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -4101.96% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1185.365% |
| Shattuck Labs, Inc. | -87.29 Million USD | -327.994% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -199.741% |
| CervoMed Inc. | -2.17 Million USD | -17103.124% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -52.133% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -737.673% |
| Aptose Biosciences Inc. | -51.2 Million USD | -629.646% |
| Precision BioSciences, Inc. | -61.31 Million USD | -509.322% |
| Dyadic International, Inc. | -6.79 Million USD | -5398.229% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -318.783% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -3445.549% |
| Nektar Therapeutics | -276.05 Million USD | -35.346% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -65564.323% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1213.194% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -427.763% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -358.926% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -65.873% |
| GRI Bio, Inc. | -13.03 Million USD | -2765.92% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -8936.714% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -201.111% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -3596.745% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -630.33% |
| IGM Biosciences, Inc. | -246.41 Million USD | -51.626% |
| INmune Bio, Inc. | -30 Million USD | -1145.101% |
| Opthea Limited | -220.24 Million USD | -69.645% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -526.003% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -283.493% |
| Verastem, Inc. | -87.36 Million USD | -327.656% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -589.507% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -131.585% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -220.278% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 816.398% |
| NextCure, Inc. | -62.72 Million USD | -495.683% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1863.489% |
| Organovo Holdings, Inc. | -14.67 Million USD | -2446.725% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -7244.759% |
| Arvinas, Inc. | -367.3 Million USD | -1.723% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -613.866% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1287.0% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -999.882% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -147.298% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1156.955% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -127.029% |
| Senti Biosciences, Inc. | -92.91 Million USD | -302.103% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -3486.491% |
| Apollomics, Inc. | -172.6 Million USD | -116.47% |
| PureTech Health plc | -65.69 Million USD | -468.717% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -846.402% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -409.401% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -154.236% |
| Synaptogenix, Inc. | -6.03 Million USD | -6087.46% |
| ChromaDex Corporation | -4.93 Million USD | -7466.424% |
| Beam Therapeutics Inc. | -132.52 Million USD | -181.927% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -4346.814% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -619.557% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -159.559% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 29.321% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -4693.391% |
| Gritstone bio, Inc. | -138.49 Million USD | -169.788% |
| Mesoblast Limited | -87.95 Million USD | -324.792% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -2359.79% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -500.161% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -132.172% |
| MediWound Ltd. | -6.71 Million USD | -5463.282% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -108.67% |
| Fortress Biotech, Inc. | -60.63 Million USD | -516.175% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -384.661% |
| Achilles Therapeutics plc | -69.66 Million USD | -436.324% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -228.541% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -620.64% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1141.543% |
| Zai Lab Limited | -334.62 Million USD | -11.658% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -6461.819% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -59.241% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 14991.59% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -174.944% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -4767.794% |
| FibroGen, Inc. | -284.23 Million USD | -31.452% |
| Celcuity Inc. | -63.77 Million USD | -485.819% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1324.329% |
| ContextLogic Inc. | -317 Million USD | -17.864% |
| GH Research PLC | -35.58 Million USD | -949.906% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -357.992% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1556.528% |
| ImmuCell Corporation | -5.77 Million USD | -6370.234% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 858.316% |
| Amarin Corporation plc | -59.11 Million USD | -532.071% |
| TG Therapeutics, Inc. | 12.67 Million USD | 3048.469% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2045.942% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -479.586% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -279.605% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1643.735% |
| Aptorum Group Limited | -2.82 Million USD | -13127.494% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 38.41% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -64.93% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1442.587% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -82.014% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1914.602% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -219.894% |
| Ardelyx, Inc. | -66.06 Million USD | -465.532% |
| Ainos, Inc. | -13.77 Million USD | -2613.254% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -496.091% |
| Prothena Corporation plc | -147.02 Million USD | -154.122% |
| HilleVax, Inc. | -123.56 Million USD | -202.373% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -228.117% |
| Celularity Inc. | -196.29 Million USD | -90.341% |
| Rallybio Corporation | -74.56 Million USD | -401.086% |
| Cue Biopharma, Inc. | -50.73 Million USD | -636.463% |
| Omeros Corporation | -117.81 Million USD | -217.138% |
| Humacyte, Inc. | -110.77 Million USD | -237.284% |
| Immunocore Holdings plc | -55.28 Million USD | -575.801% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1977.569% |
| Blueprint Medicines Corporation | -506.98 Million USD | 26.303% |
| IO Biotech, Inc. | -86.08 Million USD | -334.035% |
| MEI Pharma, Inc. | 17.77 Million USD | 2201.642% |
| GT Biopharma, Inc. | -7.59 Million USD | -4818.126% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -452.095% |
| Summit Therapeutics Inc. | -614.92 Million USD | 39.24% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -963.261% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -164.227% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -125.365% |
| Pulmatrix, Inc. | -14.12 Million USD | -2545.917% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -961.6% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -269.32% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -352.129% |
| Acelyrin, Inc. | -381.64 Million USD | 2.099% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 22.353% |
| Cytokinetics, Incorporated | -526.24 Million USD | 29.001% |
| Vor Biopharma Inc. | -117.86 Million USD | -217.004% |
| Evogene Ltd. | -23.87 Million USD | -1464.68% |
| Replimune Group, Inc. | -215.79 Million USD | -73.142% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -211.974% |
| PDS Biotechnology Corporation | -42.94 Million USD | -770.077% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -4662.415% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 41.911% |
| AEON Biopharma, Inc. | -52.55 Million USD | -610.918% |
| BioLineRx Ltd. | -60.61 Million USD | -516.409% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -809.828% |
| Atai Life Sciences N.V. | -40.22 Million USD | -828.873% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -394.737% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1172.495% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -27.872% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1240.329% |
| MediciNova, Inc. | -8.57 Million USD | -4258.972% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -203.082% |
| MiMedx Group, Inc. | 67.43 Million USD | 654.027% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -4360.277% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -56.175% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 40.372% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1168.004% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -78.463% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1139.237% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -58.36% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7697.822% |
| Allakos Inc. | -185.7 Million USD | -101.2% |
| scPharmaceuticals Inc. | -54.81 Million USD | -581.682% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -283.86% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 452.016% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2969.579% |
| Precigen, Inc. | -95.9 Million USD | -289.588% |
| XOMA Corporation | -40.83 Million USD | -815.065% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -266.771% |
| Incyte Corporation | 597.59 Million USD | 162.522% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -3655.926% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -215.265% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -326.134% |
| Seer, Inc. | -86.27 Million USD | -333.059% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1435.09% |
| CRISPR Therapeutics AG | -153.61 Million USD | -143.233% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -146.2% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -963.897% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -4517.311% |
| Akari Therapeutics, Plc | -10 Million USD | -3633.313% |
| Novavax, Inc. | -545.06 Million USD | 31.452% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -5505.936% |
| UroGen Pharma Ltd. | -102.24 Million USD | -265.43% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -249.864% |
| Entera Bio Ltd. | -8.88 Million USD | -4103.285% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1692.85% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -256.861% |
| Chimerix, Inc. | -82.09 Million USD | -355.119% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -382.801% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -85.34% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -533.457% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 190.068% |
| AnaptysBio, Inc. | -163.61 Million USD | -128.354% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -2515.219% |
| Portage Biotech Inc. | -75.33 Million USD | -395.932% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -286.56% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -441.807% |
| OKYO Pharma Limited | -16.82 Thousand USD | -2220522.794% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -2684.707% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -4370.817% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -3259.523% |
| AbCellera Biologics Inc. | -146.39 Million USD | -155.215% |
| Genprex, Inc. | -30.86 Million USD | -1110.708% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -58.368% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2969.579% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -6954.927% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1138.769% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -6609.104% |
| Bicycle Therapeutics plc | -180.66 Million USD | -106.809% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 14.377% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -373.219% |
| Erasca, Inc. | -125.04 Million USD | -198.804% |
| bluebird bio, Inc. | -211.91 Million USD | -76.313% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1422.349% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 322.87% |
| DBV Technologies S.A. | -72.72 Million USD | -413.75% |
| Fortress Biotech, Inc. | -60.63 Million USD | -516.175% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -76.058% |
| CorMedix Inc. | -46.33 Million USD | -706.293% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -235.398% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -995.657% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -660.647% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -679.712% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -164.182% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -70.056% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -94.184% |
| Onconetix, Inc. | -37.4 Million USD | -898.752% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -3641.538% |
| Prime Medicine, Inc. | -198.13 Million USD | -88.575% |
| Adagene Inc. | -18.94 Million USD | -1872.04% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -54.801% |
| GlycoMimetics, Inc. | -36.89 Million USD | -912.563% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -213.898% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -86.752% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 382.347% |
| SciSparc Ltd. | -5.12 Million USD | -7194.611% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -310600.684% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1145.211% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -412.587% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1738.297% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -554864.723% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -42.531% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -2560.065% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 15.131% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -3683.978% |
| 2seventy bio, Inc. | -217.57 Million USD | -71.729% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1223.099% |
| Clene Inc. | -49.5 Million USD | -654.747% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1576.407% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -655.816% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -13.889% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1048.115% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1744.498% |
| Absci Corporation | -110.56 Million USD | -237.925% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 109.45% |
| Surrozen, Inc. | -43.04 Million USD | -768.059% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -266.053% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -540.952% |
| Cingulate Inc. | -23.53 Million USD | -1487.554% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -5305.527% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -4745.621% |
| Jaguar Health, Inc. | -41.3 Million USD | -804.673% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -314.178% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -509.65% |
| Kronos Bio, Inc. | -112.67 Million USD | -231.606% |
| Innoviva, Inc. | 179.72 Million USD | 307.893% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -439.951% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -5489.08% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -280.099% |
| Soligenix, Inc. | -6.14 Million USD | -5984.456% |
| AlloVir, Inc. | -190.41 Million USD | -96.216% |
| Century Therapeutics, Inc. | -136.67 Million USD | -173.375% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -271.044% |
| Kura Oncology, Inc. | -152.63 Million USD | -144.793% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 66174.239% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -419.667% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1624.34% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -900.616% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -237.946% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -785.51% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2240.797% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -2265.498% |
| HCW Biologics Inc. | -24.99 Million USD | -1394.862% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -182.0% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -35.311% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -57.059% |
| Lantern Pharma Inc. | -15.96 Million USD | -2240.815% |
| Histogen Inc. | -10.62 Million USD | -3417.842% |
| Surrozen, Inc. | -43.04 Million USD | -768.059% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -826.524% |
| Kodiak Sciences Inc. | -260.49 Million USD | -43.433% |
| MoonLake Immunotherapeutics | -36 Million USD | -937.652% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -663.663% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -218.892% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1084.472% |
| Moderna, Inc. | -4.71 Billion USD | 92.074% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -2.005% |
| Turnstone Biologics Corp. | -55.2 Million USD | -576.866% |
| Immix Biopharma, Inc. | -15.42 Million USD | -2322.072% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -2205.22% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -378.89% |
| Exelixis, Inc. | 207.76 Million USD | 279.833% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -176.043% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -549.644% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -69737.383% |
| Alkermes plc | 355.75 Million USD | 205.024% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -479.586% |
| Arcellx, Inc. | -70.69 Million USD | -428.547% |
| ESSA Pharma Inc. | -26.58 Million USD | -1305.557% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -9240.867% |
| Avid Bioservices, Inc. | -140.75 Million USD | -165.451% |
| Insmed Incorporated | -749.56 Million USD | 50.154% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -801.595% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -179.212% |
| Moolec Science SA | -51.78 Million USD | -621.448% |
| RenovoRx, Inc. | -10.23 Million USD | -3551.583% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -613.429% |
| Geron Corporation | -184.12 Million USD | -102.92% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -790.146% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -457.698% |
| Royalty Pharma plc | 1.13 Billion USD | 132.924% |
| OmniAb, Inc. | -50.61 Million USD | -638.122% |
| Alector, Inc. | -130.39 Million USD | -186.546% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -174.817% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -117.644% |
| Humacyte, Inc. | -110.77 Million USD | -237.284% |
| Structure Therapeutics Inc. | -89.62 Million USD | -316.905% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -15.323% |
| 89bio, Inc. | -142.18 Million USD | -162.77% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -3500.559% |
| Aura Biosciences, Inc. | -76.4 Million USD | -388.993% |
| Immunic, Inc. | -93.61 Million USD | -299.126% |
| Veracyte, Inc. | -74.4 Million USD | -402.164% |
| Genelux Corporation | -28.29 Million USD | -1220.387% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1185.498% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -5236.131% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1883.943% |
| Immunovant, Inc. | -259.33 Million USD | -44.072% |
| Vericel Corporation | -3.18 Million USD | -11641.986% |
| Fortrea Holdings Inc. | -3.4 Million USD | -10889.118% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -195.024% |
| XBiotech Inc. | -24.55 Million USD | -1421.481% |
| Agenus Inc. | -245.76 Million USD | -52.03% |
| Acasti Pharma Inc. | -12.85 Million USD | -2806.948% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -2885.721% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1563.694% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2240.797% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -576.952% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -447.403% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -2896.231% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1577.915% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1166.929% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1271.723% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -102.314% |
| United Therapeutics Corporation | 984.8 Million USD | 137.94% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -6967.526% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7697.822% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -7244.759% |
| Silo Pharma, Inc. | -3.7 Million USD | -9996.244% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -2758.276% |
| Pharming Group N.V. | -10.54 Million USD | -3442.188% |
| XOMA Corporation | -40.83 Million USD | -815.065% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1435.09% |
| Bionomics Limited | -15.49 Billion USD | 97.588% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1181.442% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -406.342% |
| uniQure N.V. | -308.47 Million USD | -21.12% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -389.019% |
| Cassava Sciences, Inc. | -97.21 Million USD | -284.326% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -9821.922% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1741.358% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -202.706% |
| Pluri Inc. | -20.88 Million USD | -1688.73% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -4455.517% |
| MeiraGTx Holdings plc | -84.02 Million USD | -344.655% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1529.366% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2034.28% |
| CalciMedica, Inc. | -34.35 Million USD | -987.493% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -31.906% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -146.484% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -2978766.575% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1181.442% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -256.276% |
| Nutriband Inc. | -5.48 Million USD | -6711.461% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -824.369% |
| Compugen Ltd. | -18.75 Million USD | -1892.268% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 108.591% |
| ProKidney Corp. | -35.46 Million USD | -953.428% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -7371.857% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -8586.005% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -267.226% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -363.272% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -711.375% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1617.76% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1338.878% |
| Biomea Fusion, Inc. | -117.25 Million USD | -218.647% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -143.944% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -270.529% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 2752.869% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1578.482% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -10.284% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -93.629% |
| Imunon, Inc. | -19.51 Million USD | -1814.581% |
| BioAtla, Inc. | -123.46 Million USD | -202.628% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -14.167% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -911.205% |
| Zura Bio Limited | -60.36 Million USD | -519.003% |
| aTyr Pharma, Inc. | -50.38 Million USD | -641.491% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -57.163% |
| Galecto, Inc. | -38.34 Million USD | -874.289% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -554864.723% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 232.684% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -110.949% |
| PolyPid Ltd. | -23.86 Million USD | -1465.598% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -2274.968% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1087.031% |
| Xencor, Inc. | -126.08 Million USD | -196.327% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1656.892% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -5505.936% |
| Instil Bio, Inc. | -156.08 Million USD | -139.373% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -4360.277% |
| OncoCyte Corporation | -27.78 Million USD | -1244.912% |
| Elevation Oncology, Inc. | -45.7 Million USD | -717.5% |
| Purple Biotech Ltd. | -19.88 Million USD | -1779.427% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -5223.123% |
| MacroGenics, Inc. | -9.05 Million USD | -4024.862% |
| Verona Pharma plc | -54.36 Million USD | -587.211% |
| Tharimmune, Inc. | -9.31 Million USD | -3909.295% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -344.877% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -273.94% |
| Aditxt, Inc. | -32.38 Million USD | -1053.861% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -20866.891% |
| Savara Inc. | -54.69 Million USD | -583.078% |
| Curis, Inc. | -47.41 Million USD | -688.033% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -2319.086% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1153.161% |
| BeiGene, Ltd. | -881.7 Million USD | 57.624% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -7371.857% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -830.423% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -2705.873% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -518.716% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1389.1% |
| Adicet Bio, Inc. | -142.65 Million USD | -161.906% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5010.013% |
| Quantum-Si incorporated | -95.96 Million USD | -289.36% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2463.012% |
| Generation Bio Co. | -126.61 Million USD | -195.098% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -353.203% |
| Invivyd, Inc. | -198.64 Million USD | -88.091% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -9.257% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -4201.236% |
| Moolec Science SA | -51.78 Million USD | -621.448% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1050.162% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -586.542% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -278.2% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -132.35% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 39.253% |
| Evaxion Biotech A/S | -22.12 Million USD | -1588.723% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -362.78% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -440.443% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -837.356% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -527.918% |
| Clearmind Medicine Inc. | -11.95 Million USD | -3025.295% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -468.129% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 623.218% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -14731608.086% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -334.985% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -144.215% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -74.163% |
| ImmunityBio, Inc. | -583.19 Million USD | 35.934% |
| Korro Bio, Inc. | -81.17 Million USD | -360.294% |
| Kineta, Inc. | -14.09 Million USD | -2550.046% |
| BioVie Inc. | -32.12 Million USD | -1063.212% |
| Codexis, Inc. | -76.24 Million USD | -390.071% |
| Celularity Inc. | -196.29 Million USD | -90.341% |
| Virax Biolabs Group Limited | -6.73 Million USD | -5448.793% |
| Cibus, Inc. | -267.62 Million USD | -39.608% |
| Annexon, Inc. | -134.23 Million USD | -178.336% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -510.227% |
| Eyenovia, Inc. | -27.26 Million USD | -1270.561% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1830.49% |
| NeurAxis, Inc. | -14.62 Million USD | -2454.441% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1143.899% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -779.254% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1658.819% |
| Notable Labs, Ltd. | -11.26 Million USD | -3217.028% |
| IN8bio, Inc. | -30 Million USD | -1145.143% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1827.816% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -289.238% |
| Lumos Pharma, Inc. | -34.03 Million USD | -997.814% |
| Liquidia Corporation | -78.5 Million USD | -375.95% |
| Mustang Bio, Inc. | -51.6 Million USD | -624.061% |
| Quantum-Si incorporated | -95.96 Million USD | -289.36% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -412.883% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -273.94% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -587.262% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1774.231% |
| Vaxcyte, Inc. | -402.26 Million USD | 7.119% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -104.849% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5010.013% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -350.406% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 12517.949% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -14731608.086% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -858.321% |
| PepGen Inc. | -78.62 Million USD | -375.199% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1155.098% |
| Solid Biosciences Inc. | -96.01 Million USD | -289.137% |
| Palisade Bio, Inc. | -12.3 Million USD | -2937.642% |
| Nutriband Inc. | -5.48 Million USD | -6711.461% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -69737.383% |
| Immuneering Corporation | -53.47 Million USD | -598.744% |
| Belite Bio, Inc | -31.63 Million USD | -1081.177% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -668.675% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1338.878% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -786.977% |
| Altimmune, Inc. | -88.44 Million USD | -322.434% |
| Peak Bio, Inc. | -1259.26 USD | -29670500.194% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1324.329% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -2166.485% |
| Neurogene Inc. | -36.31 Million USD | -928.802% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -128.639% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -4295.13% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -280.684% |
| Sesen Bio, Inc. | -19.88 Million USD | -1779.048% |
| argenx SE | -295.05 Million USD | -26.631% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -350.406% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -757.835% |
| Immunome, Inc. | -106.8 Million USD | -249.821% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -2160643.893% |
| Design Therapeutics, Inc. | -66.86 Million USD | -458.808% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -886.3% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -421.946% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 15.856% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -234.896% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -176.523% |
| Athira Pharma, Inc. | -117.67 Million USD | -217.518% |
| XOMA Corporation | -40.83 Million USD | -815.065% |
| Merus N.V. | -154.93 Million USD | -141.147% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1090.473% |
| Rezolute, Inc. | -68.45 Million USD | -445.772% |
| Clene Inc. | -49.5 Million USD | -654.747% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2322.477% |
| BeyondSpring Inc. | -21.02 Million USD | -1676.99% |
| Synlogic, Inc. | -57.28 Million USD | -552.264% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -3039.484% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3351.229% |
| Peak Bio, Inc. | -1259.26 USD | -29670500.194% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -899.866% |
| Krystal Biotech, Inc. | 10.93 Million USD | 3517.764% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -161.099% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -14.926% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -7989.042% |
| MannKind Corporation | -11.93 Million USD | -3029.754% |
| Ikena Oncology, Inc. | -68.16 Million USD | -448.118% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1677.921% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -302.042% |
| Gossamer Bio, Inc. | -179.81 Million USD | -107.783% |
| CohBar, Inc. | -11.96 Million USD | -3023.443% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1348.852% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1139.237% |
| Legend Biotech Corporation | -518.25 Million USD | 27.906% |
| Mural Oncology plc | -207.44 Million USD | -80.109% |
| Disc Medicine, Inc. | -76.42 Million USD | -388.859% |
| Champions Oncology, Inc. | -7.27 Million USD | -5035.102% |
| REGENXBIO Inc. | -263.49 Million USD | -41.798% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -3420.469% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -686.507% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -883.664% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -273.022% |
| Vaxart, Inc. | -82.46 Million USD | -353.077% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 112044.703% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -895.218% |
| Cellectis S.A. | -101.05 Million USD | -269.715% |
| Longeveron Inc. | -21.41 Million USD | -1644.875% |
| Repare Therapeutics Inc. | -93.79 Million USD | -298.343% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 30.29% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -424.99% |
| Revolution Medicines, Inc. | -436.36 Million USD | 14.377% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -5586.045% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1112.14% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -438.892% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -477.195% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -3708.276% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 110.322% |
| Denali Therapeutics Inc. | -145.22 Million USD | -157.278% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -310600.684% |
| Veru Inc. | -93.15 Million USD | -301.094% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1282.33% |
| Cingulate Inc. | -23.53 Million USD | -1487.554% |
| Passage Bio, Inc. | -102.06 Million USD | -266.081% |
| Context Therapeutics Inc. | -23.96 Million USD | -1459.117% |
| Exicure, Inc. | -16.91 Million USD | -2108.998% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -97.775% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -889.381% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -5641.684% |
| Nuvalent, Inc. | -126.21 Million USD | -196.017% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -3453.083% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -330.058% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1123.252% |
| OmniAb, Inc. | -50.61 Million USD | -638.122% |
| Anew Medical, Inc. | 1.34 Million USD | 27855.966% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -2228.638% |
| Lipocine Inc. | -16.35 Million USD | -2184.908% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -462.747% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -486.777% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -785.51% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -678.931% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1784.07% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 31.0% |
| Ocugen, Inc. | -63.07 Million USD | -492.33% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -290.287% |
| Q32 Bio Inc. | -112.96 Million USD | -230.76% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2073.278% |
| Alumis Inc. Common Stock | -154.99 Million USD | -141.062% |
| Equillium, Inc. | -13.33 Million USD | -2701.875% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -518.941% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -4577.487% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1881.993% |
| Dominari Holdings Inc. | -22.88 Million USD | -1532.856% |
| Edesa Biotech, Inc. | -8.37 Million USD | -4361.565% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1745.086% |
| Bio-Techne Corporation | 168.1 Million USD | 322.26% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -6.118% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 389.966% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -206.676% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -884.818% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -231.697% |
| Nkarta, Inc. | -117.5 Million USD | -217.98% |
| BioCardia, Inc. | -11.57 Million USD | -3129.021% |
| Iterum Therapeutics plc | -38.37 Million USD | -873.73% |